A glimpse into the 13th chamber – overt and covert manifestations of diabetes mellitus

Česká verzia

Authors: Jozef Lacka
Authors place of work: JAL, s. r. o., Trnava
Published in the journal: Diab Obez 2023; 23(45): 67-70
Category: News

Zdroje

1. Siracusa R, Fusco R. Cuzzocrea S. Astrocytes: Role and Functions in Brain Pathologies. Front Pharmacol 2019; 10: 1114. Dostupné z DOI: <https://doi.org/10.3389/fphar.2019.01114>.

2. Gandhi GK, Ball KK, Cruz NF et al. Hyperglycaemia and diabetes impair gap junctional communication among astrocytes. ASN Neuro 2010; 2(2): e00030. Dostupné z DOI: <http://dx.doi.org/10.1042/AN20090048>.

3. Soehnlein O, Libby P. Targeting inflammation in atherosclerosis — from experimental insights to the clinic. Nat Rev Drug Discov 2021; 20(8): 589–610. Dostupné z DOI: <https://doi.org/10.1038/s41573–021–00198–1>.

4. Pretorius L, Thomson GJA, Adams RCM et al. Platelet activity and hypercoagulation in type 2 diabetes. Cardiovasc Diabetol 2018; 17(1): 141. Dostupné z DOI: <http://dx.doi.org/10.1186/s12933–018–0783-z>.

5. Tardif J, Kouz S, Waters DD et al. Efficacy and Safety of Low-Dose Colchicine after Myocardial Infarction. N Engl J Med 2019; 381(26): 2497–2505. Dostupné z DOI: <http://dx.doi.org/10.1056/NEJMoa1912388>.

6. Yamanouchi M, Furuichi K, Hoshino J et al. Nonproteinuric diabetic kidney disease. Clin Exp Nephrol 2020; 24(7): 573–581. Dostupné z DOI: <http://dx.doi.org/10.1007/s10157–020–01881–0>.

7. D’Marco L, Guerra-Torres X, Viejo I et al. Non-albuminuric Diabetic Kidney Disease Phenotype: Beyond Albuminuria. Endocrinol. 2022; 18(2): 102–105. Dostupné z DOI: <http://dx.doi.org/10.17925/EE.2022.18.2.102>.

8. Kamenov ZA. A comprehensive review of erectile dysfunction in men with diabetes. Exp Clin Endocrinol Diabetes 2015; 123(3): 141–158. <http://dx.doi.org/10.1055/s-0034–1394383>.

9. Rosen RC, Riley A, Wagner G et al. The International Index of Erectile Function (IIEF): a multidimensional scale for assessment of erectile dysfunction. Urology 1997; 49(6): 822–830. Dostupné z DOI: <http://dx.doi.org/10.1016/s0090–4295(97)00238–0>.

10. Tajar A, Huhtaniemi IT, O’Neill TW et al. [EMAS Group]. Characteristics of Androgen Deficiency in Late-Onset Hypogonadism: Results from the European Male Aging Study (EMAS). J Clin Endocrinol Metab 2012; 97(5): 1508–1516. Dostupné z DOI: <https://doi.org/10.1210/jc.2011–2513>.